Effects of ALK inhibitors (PF-02341066 and PF-06463922) with radiotherapy in EML4 – ALK fusion positive (H2228 and 185IG) and negative (A549) experimental lung cancer cell lines.

Saved in:
Bibliographic Details
Title: Effects of ALK inhibitors (PF-02341066 and PF-06463922) with radiotherapy in EML4 – ALK fusion positive (H2228 and 185IG) and negative (A549) experimental lung cancer cell lines.
Authors: Antoni, D.N.1,2 (AUTHOR), Burckel, H.2 (AUTHOR), Noel, G.1,2 (AUTHOR)
Source: International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pe507-e508. 2p.
Subjects: Anaplastic lymphoma kinase, Cell lines, Lung cancer, Cancer cells, Non-small-cell lung carcinoma
Database: Engineering Source
Description
ISSN:03603016
DOI:10.1016/j.ijrobp.2020.07.1599